ArticleFrontiers in pharmacology2021

Fenofibrate Improves Insulin Resistance and Hepatic Steatosis and Regulates the Let-7/SERCA2b Axis in High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease Mice.

Dan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.